📣Gyn-SMART (BIG) Winter Edition.⏰Jan 16th at 4-5:30pm. Systemic therapy in locally advanced cervical cancer: A18, INTERLACE and standard of care chemoradiotherapy perspectives. ⬇️Register here (for free) and ask questions to panelists . Happy holidays! .

RT @rafeequemavoor: Free scientific illustrations for biologists! 😍. @NIH has released a library of 500+ free scientific illustrations to….

Join millions who have switched to Grok.

Check out this new #RedJournal Outtake on the results of the BIOEMBRACE study ⬇️. @Supriya_Sastri @KariTanderup @NandaHoreweg.

RT @EORTC_QLG: Patient-reported outcomes (PROs) are essential in cancer #ClinicalTrials, but low completion rates & missing data can impact….

Great success for Gyn-SMART late Summer Edition!. Setting the record with 160 registered participants from 32 countries worldwide 🌍🌎🌏. Thanks to the speakers for their contribution!. Did you miss it? Don't panic, recording is available on our website⬇️.

📣 New article out. Association between the regular use of vaginal dilators and/or sexual activity and vaginal morbidity in locally advanced cervical cancer survivors - An EMBRACE-I study report. Regular dilation associated with less vaginal stenosis!.

Should we refer to "women" and "men" in scientific articles for gynecological and prostate tumor?. I think that the disease affects a part of the body, regardless of gender constructs and identification. Personally, I hope to see more neutral and inclusive language in research.

📣 Gyn-SMART is back!. The webinar series returns for a (late) summer edition on "Molecular classification of endometrial cancer: how does it work and what does it imply for treatment and outcome?". ⏰ September 19, 4pm-5pm (CEST). Register here ⬇️.

🍻 Great post-birthday celebrations presenting at @pintofscienceNL!. How can we use #AI for data directly generated by #cancer patients?. Unlocking this tool for patient-centered #healthcare, aware of limitations and skepticism.

☀️Preparing my presentation for @pintofscienceNL in a cozy cafe in Cambridge, sun is shining, and the weekend is around the corner!. Always happy to share my favorite research topic: #DataScience for #Cancer patients. If you're close by, join the event on May 14 in Rotterdam!

#ESTRO24 wrap-up! Next stop: Cambridge for some couchsurfing with friends. Couldn't totally #GoGreenESTRO24, but all my outfits at the conference were thrifted/swapped. Be aware of the negative impact of fast fashion on the environment. 👗Buy less, thrift more (it's fun)!

New findings on acute gastrointestinal toxicity from the large international EMBRACE II study in cervical #Cancer presented at #ESTRO24 by Mayuri Charnalia!. Highly conformal and image-guided RT is well tolerated even in patients with para-aortic fields and lymph node boosting.

First time presenting at an Education session at #ESTRO2024, and it was a blast! . House was full, relevant questions, and great speakers! . This is just the first step for BRIDGE, to raise awareness on accurate morbidity scoring in #clinicaltrials. Let's not compare🍎 with 🍊!

Chronicles for ##ESTRO24: learned about inequities in #RT, value-based #healthcare, that research is underfunded, fairness in #AI with @cancerphysicist brilliant talk, and co-chaired an amazing session on #MachineLearning for prediction. 🧠 overload, but please give me more!.

#ESTRO24: that amazing moment of the year when I can meet in person my collaborators scattered around the world 🌎🌍🌏.It's so nice to see you in 3D, and not on a screen! .And this time even more emotional, I can also hug my colleagues from @DCPTprotons 🥹.Jeg savner dig!.

🍺 On May 14 I am happy to be a speaker for @pintofscienceNL Rotterdam, where I will talk about #AI applications for patient-generated data in #Oncology. 🍻 Grab your favorite drink(s) and explore AI potential, limitations and skepticism. Tickets here:

Looking forward to #ESTRO24! . We present BRIDGE, the initiative I'm leading on the importance of toxicity scoring. This could not be possible without my wonderful team 🌉. Join the Mini-Oral session "Education and training for next-generation radiation oncology".⏰ May 6, 10:30.

And while Northern Europe in mid-April witnesses strange weather phenomena alternating mild springs and freezing winters, I run into another interesting phenomenon known as the manuscript-storm, in which I have to handle 4 manuscripts in the space of a week.

I guess my highest academic achievement is the ability to cut any manuscript below a 3k words limit.

You realize you've spent too much time abroad when you get excited about the frozen #parmigiana from the Italian week at Lidl that you've jealously stored in the fridge for special occasions. Yes, I had the whole thing. Crazy Fridays.